Author:
Dummer R.,Becker J. C.,Hartmann A. A.,Eilles C.,Burg G.
Publisher
Springer Berlin Heidelberg
Reference25 articles.
1. Balch CM, Hersey P (1985) Heutiger Stand der adjuvanten Therapie. In: Balch CM, Milton GW, Shaw HM, Seng-jaw Soong (Hrsg). Hautmelanome. Diagnose, Therapie und weltweite Ergebnisse. Springer Verlag, Berlin Heidelberg New York, S 192–212
2. Becker JC, Dummer R, Burg G, Schmidt RE (1991) Shedding of ICAM-1 from human melanoma cell lines induced by interferon-gamma and tumors necrosis factor alpha: Functional consequences on cell mediated cytotoxicity. Immunol 147: 4398–4401
3. Berd D, Maguire HC, McCue P, Mastrangelo MJ (1990) Treatment of metastatic melanoma with an antologous tumor-cell vaccine: clinical and immunological results in 64 patients. J Clin Oncol 8: 1858–1867
4. Bergmann L, Weidmann E, Mitrou PS, Runne U, Keilholz U, Bartsch HH, Franks CR (1990) Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. Onkologie 13: 137–140
5. Bystryn JC (1989) Immunosurveillance and melanoma. J Invest Dermatol 92: S318–320